Samsung has launched blood pressure monitoring capabilities for select users of its Galaxy Watch8 and Galaxy Watch8 Classic in the United States, expanding its wearable health ecosystem through the Samsung Health Monitor App. The feature enables users to estimate systolic and diastolic blood pressure directly from their wrist using the device’s internal sensors.
The system relies on pulse wave analysis, leveraging the smartwatch’s advanced heart rate monitoring sensors to estimate blood pressure changes. To maintain accuracy, Samsung requires users to calibrate the device every 28 days using a traditional upper arm cuff. This hybrid approach combines the clinical reliability of cuff-based measurements with the convenience of continuous wearable monitoring.
The calibration process allows the system’s AI models to establish an individualized baseline, enabling more accurate tracking of fluctuations throughout the day. While the watch provides ongoing insights, Samsung emphasizes that the feature is not intended for diagnosis or prevention of hypertension.
“It is not intended to prevent or diagnose high blood pressure,” Samsung’s disclaimer reads—and this is a critical distinction. This positioning underscores the device’s role as a behavioral health tool rather than a replacement for clinical assessment.
Samsung plans to introduce passive blood pressure monitoring later in the year, enabling users to track long-term trends automatically. This functionality is expected to highlight how lifestyle factors such as sleep, diet and stress influence cardiovascular health over time.
The launch addresses a significant public health issue, with nearly 120 million U.S. adults affected by high blood pressure in 2025. By providing continuous visibility into blood pressure patterns, the Galaxy Watch8 aims to support earlier awareness of potential risks.
This feature builds on Samsung’s broader health platform strategy, which includes its FDA-authorized sleep apnea detection capability. Together, these tools position the smartwatch as a centralized interface for personal health monitoring, integrating multiple data streams into a single consumer device.
As wearable technologies continue to evolve, Samsung’s approach reflects a growing emphasis on combining clinical validation with consumer accessibility, particularly in managing chronic conditions such as hypertension.
Click here for the original news story.